NLRP3 and pulmonary fibrosis: Studies have demonstrated that the activated NLRP3 inflammasome can promote pulmonary EMT via the IL-1β/IL-1Rs/MyD88/NF-κB signaling pathway, leading to pulmonary fibrosis (14).